| Application no. and date | 08796910.1 (espacenet) (Federated) (European Patent Register), 20080731 | | Patent/reg. no. and date | DK/EP 2178863, 20121024 | | Publication date | 20100428 | | Priority no. and date | US 954595 P, 20070808 | | EP pub. no. and date |
EP 2178863 20100428 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | 12167-2 | | Inventor | PACK, Shawn, K., c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
GENG, Peng, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
HAMM, Jason, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
SMITH, Michael, J., c/o Bristol-Myers Squibb Company
Bldg. 48; Room 252
Mail Stop: NB48-22-211
1 Squibb Drive
New Brunswick, New Jersey 08903, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | C07D 403/14 (2006.01) | | Title | Fremgangsmåde til syntetisering af anvendelige forbindelser til behandling af hepatitis C | | Int. application no. | US2008071696 | | Int. publication no. | WO2009020825 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
